MedTrace Logo

Danish ICD Study in Patients With Dilated Cardiomyopathy

NCT00542945 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1116

Last updated 2019-07-18

No results posted yet for this study

Summary

The primary objective of this study is to determine the efficacy of ICD therapy compared with control on the endpoint of death from any cause in patients with heart failure of non-ischemic oetiology.

Conditions

Interventions

DEVICE

ICD

Implantation of an ICD

OTHER

Optimal medical treatment

ACE-inhibitors or ARB Beta-blocker Optional aldosterone antagonist

Sponsors & Collaborators

  • Danish Heart Foundation

    collaborator OTHER

  • Danish Study Group

    lead NETWORK

Principal Investigators

  • Lars Køber, MD, D.Sci · Department of Cardiology, Rigshospitalet.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00542945 on ClinicalTrials.gov